Compare Kidswell Bio Corp. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 2.20%
- The company has been able to generate a Return on Capital Employed (avg) of 2.20% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -34.17
3
The company has declared Positive results for the last 3 consecutive quarters
4
With ROE of -1.95%, it has a risky valuation with a 7.40 Price to Book Value
5
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
JPY 12,891 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.19
13.33%
5.90
Revenue and Profits:
Net Sales:
1,556 Million
(Quarterly Results - Sep 2025)
Net Profit:
-97 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.0%
0%
-2.0%
6 Months
-9.59%
0%
-9.59%
1 Year
128.97%
0%
128.97%
2 Years
82.84%
0%
82.84%
3 Years
-15.52%
0%
-15.52%
4 Years
-42.22%
0%
-42.22%
5 Years
-55.7%
0%
-55.7%
Kidswell Bio Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
36.37%
EBIT Growth (5y)
15.14%
EBIT to Interest (avg)
-34.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
1.17
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.20%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.40
EV to EBIT
332.98
EV to EBITDA
322.57
EV to Capital Employed
36.62
EV to Sales
1.83
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.00%
ROE (Latest)
-1.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
1,555.60
1,720.60
-9.59%
Operating Profit (PBDIT) excl Other Income
30.70
184.70
-83.38%
Interest
8.20
9.60
-14.58%
Exceptional Items
10.60
0.00
Consolidate Net Profit
-96.50
157.10
-161.43%
Operating Profit Margin (Excl OI)
19.70%
107.30%
-8.76%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -9.59% vs -15.89% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -161.43% vs -5.70% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
5,082.10
2,431.20
109.04%
Operating Profit (PBDIT) excl Other Income
28.80
-1,334.70
102.16%
Interest
42.50
38.80
9.54%
Exceptional Items
1.40
-30.90
104.53%
Consolidate Net Profit
-21.10
-1,422.10
98.52%
Operating Profit Margin (Excl OI)
5.50%
-549.30%
55.48%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 109.04% vs -12.43% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 98.52% vs -116.32% in Mar 2024
About Kidswell Bio Corp. 
Kidswell Bio Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






